Exactech, a medical device manufacturer, has reached an agreement to pay million to resolve allegations that it hid flaws in its widely used artificial knee implant products. These allegations stem from thousands of patient injury lawsuits. The settlement specifically addresses two whistleblower claims asserting that the Florida-based company knowingly billed government health care programs, such as Medicare, for knee replacement parts that were defective.

U.S. Attorney for the District of Maryland, Kelly Hayes, emphasized the importance of device manufacturers prioritizing patient safety, stating that companies must promptly and transparently address any defects once identified. Exactech, which had grown significantly from its origins, filed for bankruptcy in October, leaving many patients seeking compensation in a state of uncertainty. Despite the settlement, Exactech has not admitted to liability, and the U.S. Bankruptcy Court for the District of Delaware has given its approval to the agreement. A previous investigation by KFF Health News in October 2023 highlighted the issues surrounding Exactech's products.

Joseph Saunders, a Florida attorney representing affected patients, noted that over 2,500 individuals have filed claims for injuries, with many requiring multiple surgeries to replace faulty implants, some within three years of the initial procedure. These cases are currently on hold due to the bankruptcy proceedings. Patients like Sue Sacker, who underwent two Exactech knee implant replacements, expressed significant disappointment with the settlement, feeling that the focus was on government compensation rather than patient relief. Efforts are ongoing by a creditors' committee to pursue TPG, a private equity firm that acquired Exactech in 2018, although TPG successfully dismissed a similar attempt last year by arguing it had no operational control over Exactech.

Two whistleblower cases played a crucial role in bringing these issues to light. The first, filed in 2018 by former Exactech sales agents Brooks Wallace and Robert Farley, along with former product manager Manuel Fuentes, alleged severe defects in the Optetrak knee replacement systems. They claimed Exactech knew as early as 2008 about premature failure rates but continued to market the implants until 2018. These whistleblowers are set to receive over .3 million from the settlement. The second case involved Maryland orthopedic surgeon Pasquale Petrera, who asserted that Exactech was aware of premature failures in certain Logic and Truliant brand knee system components from 2019 but continued sales until a product recall in early 2022. Petrera will receive over 5,000. KFF Health News' analysis in 2023 revealed approximately 400 instances where Exactech delayed reporting adverse events to the government, often exceeding the mandated 30-day window. Furthermore, an examination of over 300 pending cases in Florida's Alachua County indicated that about 200 knee and hip implants were removed well before their expected lifespan of 15-20 years, despite Exactech's advertisements emphasizing durability. In legal proceedings, Exactech consistently denied any defects in its Optetrak line.

The pursuit of justice and accountability in the medical device industry is paramount for patient safety and trust. When companies fail to uphold their responsibility, it is essential that mechanisms exist to hold them accountable and ensure that those harmed receive appropriate recourse. This case underscores the ongoing need for rigorous oversight and transparent practices to protect public health and well-being, fostering a system where integrity and patient welfare are always prioritized.